News

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

News

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

News

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

News

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

News

XORTX Announces Participation at Upcoming Investor Conferences

News

XORTX Announces Participation at Upcoming Investor Conferences

News

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

News

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

News

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

News

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

News

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

News

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

News

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

News

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

News

Borqs Technologies, Inc. featured in an updated research report by WallStreet Research™ with a “Speculative Buy” Rating

SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…

News

Borqs Technologies, Inc. featured in an updated research report by WallStreet Research™ with a “Speculative Buy” Rating

SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”,…

News

VERB’s MARKET.live Launches Affiliate Sales Program on TikTok

Represents An Exciting Expansion of New Strategic TikTok Relationship LOS ALAMITOS, Calif. and LEHI, Utah,…

News

VERB’s MARKET.live Launches Affiliate Sales Program on TikTok

Represents An Exciting Expansion of New Strategic TikTok Relationship LOS ALAMITOS, Calif. and LEHI, Utah,…

News

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

XORTX Announces Participation at Upcoming Investor Conferences

XORTX Announces Participation at Upcoming Investor Conferences

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

Borqs Technologies, Inc. featured in an updated research report by WallStreet Research™ with a “Speculative Buy” Rating

Borqs Technologies, Inc. featured in an updated research report by WallStreet Research™ with a “Speculative Buy” Rating

VERB’s MARKET.live Launches Affiliate Sales Program on TikTok

VERB’s MARKET.live Launches Affiliate Sales Program on TikTok

You may have missed

Cheelcare Announces a Non-Brokered Private Placement to Raise up to $1.5 Million

AISIX Solutions Inc. and Re: Drying Equipment Inc. Announce Proposed Reverse Takeover Transaction

Ningbo Sincere Holding Group Launches FIFA World Cup 2026 Licensed Pet Product Collection

Investor Pointe Launches, Combining AI-Powered Technology, Specialist Services, and Tailored Solutions for Private Markets

BrandPilot AI Signs Agency Agreement with Epitaph Group